Limits...
The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy.

Lee Y, Kim BK, Lim YH, Kim MK, Choi BY, Shin J - PLoS ONE (2013)

Bottom Line: Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (β = 0.079, p = 0.001).The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI.Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiology, Hanyang University Hospital, Seoul, Republic of Korea ; Cardiology Clinic, Myungji St. Mary's Hospital, Seoul, Republic of Korea.

ABSTRACT

Background: Adiponectin directly protects against cardiac remodeling. Despite this beneficial effect, most epidemiological studies have reported a negative relationship between adiponectin level and left ventricular mass index (LVMI). However, a positive relationship has also been reported in subjects at high risk of left ventricular hypertrophy (LVH). Based on these conflicting results, we hypothesized that the relationship between serum adiponectin level and LVMI varies with the risk of LVH.

Methods: A community-based, cross-sectional study was performed on 1414 subjects. LVMI was measured by echocardiography. Log-transformed adiponectin levels (Log-ADPN) were used for the analysis.

Results: Serum adiponectin level had a biphasic distribution (an increase after a decrease) with increasing LVMI. Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (β = 0.079, p = 0.001). The relationship between adiponectin level and LVMI was bidirectional according to the risk of LVH. In normotensive subjects younger than 50 years, Log-ADPN negatively correlated with LVMI (r = -0.204, p = 0.005); however, Log-ADPN positively correlated with LVMI in ≥50-year-old obese subjects with high arterial stiffness (r = 0.189, p = 0.030). The correlation coefficient between Log-ADPN and LVMI gradually changed from negative to positive with increasing risk factors for LVH. The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI. In the multivariate analysis, Log-ADPN was associated with LVMI in the subjects at risk of LVH; however, Log-ADPN was either not associated or negatively associated with LVMI in subjects at low risk of LVH.

Conclusion: Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH. Therefore, the relationship between adiponectin and LVMI varies with the risk of LVH.

Show MeSH

Related in: MedlinePlus

The adiponectin level and LVMI according to the severity of LVH.The bars and whiskers indicate the means and standard deviations. * Subjects without hypertension, obesity (body mass index ≥25 kg/m2), impaired fasting glucose and LVH. LVMI increases with the severity of LVH. Adiponectin in the healthy subjects is higher than in subjects without LVH, whereas adiponectin in subjects without LVH is lower than in subjects with moderate to severe LVH. LVMI, left ventricular mass index; LVH, left ventricular hypertrophy.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3722139&req=5

pone-0070246-g001: The adiponectin level and LVMI according to the severity of LVH.The bars and whiskers indicate the means and standard deviations. * Subjects without hypertension, obesity (body mass index ≥25 kg/m2), impaired fasting glucose and LVH. LVMI increases with the severity of LVH. Adiponectin in the healthy subjects is higher than in subjects without LVH, whereas adiponectin in subjects without LVH is lower than in subjects with moderate to severe LVH. LVMI, left ventricular mass index; LVH, left ventricular hypertrophy.

Mentions: LVMI gradually increased with the severity of LVH. However, the adiponectin level showed a biphasic distribution; a decrease in the no LVH group compared to the healthy subjects and an increase in the moderate to severe LVH group compared to the no LVH group (Figure 1). LVMI positively correlated with BMI, SBP, age and Log-HOMA-IR, negatively correlated with male gender and did not correlate with Log-ADPN (Table 2). In a stepwise multiple linear regression analysis, LVMI was positively associated with BMI, age, SBP and Log-ADPN and was not associated with Log-HOMA-IR or male gender. BMI was the strongest determinant of LVMI, whereas Log-ADPN was only a modest determinant of LVMI (β = 0.079, p = 0.001) (Table 2). LVMI and Log-ADPN were negatively correlated in the no LVH group and mild LVH group (r = −0.125, p = 0.003 and r = −0.273, p<0.001, respectively), but they did not correlate in the healthy subject group or moderate to severe LVH group (r = −0.038, p>0.05 and r = 0.045, p>0.05, respectively).


The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy.

Lee Y, Kim BK, Lim YH, Kim MK, Choi BY, Shin J - PLoS ONE (2013)

The adiponectin level and LVMI according to the severity of LVH.The bars and whiskers indicate the means and standard deviations. * Subjects without hypertension, obesity (body mass index ≥25 kg/m2), impaired fasting glucose and LVH. LVMI increases with the severity of LVH. Adiponectin in the healthy subjects is higher than in subjects without LVH, whereas adiponectin in subjects without LVH is lower than in subjects with moderate to severe LVH. LVMI, left ventricular mass index; LVH, left ventricular hypertrophy.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3722139&req=5

pone-0070246-g001: The adiponectin level and LVMI according to the severity of LVH.The bars and whiskers indicate the means and standard deviations. * Subjects without hypertension, obesity (body mass index ≥25 kg/m2), impaired fasting glucose and LVH. LVMI increases with the severity of LVH. Adiponectin in the healthy subjects is higher than in subjects without LVH, whereas adiponectin in subjects without LVH is lower than in subjects with moderate to severe LVH. LVMI, left ventricular mass index; LVH, left ventricular hypertrophy.
Mentions: LVMI gradually increased with the severity of LVH. However, the adiponectin level showed a biphasic distribution; a decrease in the no LVH group compared to the healthy subjects and an increase in the moderate to severe LVH group compared to the no LVH group (Figure 1). LVMI positively correlated with BMI, SBP, age and Log-HOMA-IR, negatively correlated with male gender and did not correlate with Log-ADPN (Table 2). In a stepwise multiple linear regression analysis, LVMI was positively associated with BMI, age, SBP and Log-ADPN and was not associated with Log-HOMA-IR or male gender. BMI was the strongest determinant of LVMI, whereas Log-ADPN was only a modest determinant of LVMI (β = 0.079, p = 0.001) (Table 2). LVMI and Log-ADPN were negatively correlated in the no LVH group and mild LVH group (r = −0.125, p = 0.003 and r = −0.273, p<0.001, respectively), but they did not correlate in the healthy subject group or moderate to severe LVH group (r = −0.038, p>0.05 and r = 0.045, p>0.05, respectively).

Bottom Line: Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (β = 0.079, p = 0.001).The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI.Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiology, Hanyang University Hospital, Seoul, Republic of Korea ; Cardiology Clinic, Myungji St. Mary's Hospital, Seoul, Republic of Korea.

ABSTRACT

Background: Adiponectin directly protects against cardiac remodeling. Despite this beneficial effect, most epidemiological studies have reported a negative relationship between adiponectin level and left ventricular mass index (LVMI). However, a positive relationship has also been reported in subjects at high risk of left ventricular hypertrophy (LVH). Based on these conflicting results, we hypothesized that the relationship between serum adiponectin level and LVMI varies with the risk of LVH.

Methods: A community-based, cross-sectional study was performed on 1414 subjects. LVMI was measured by echocardiography. Log-transformed adiponectin levels (Log-ADPN) were used for the analysis.

Results: Serum adiponectin level had a biphasic distribution (an increase after a decrease) with increasing LVMI. Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (β = 0.079, p = 0.001). The relationship between adiponectin level and LVMI was bidirectional according to the risk of LVH. In normotensive subjects younger than 50 years, Log-ADPN negatively correlated with LVMI (r = -0.204, p = 0.005); however, Log-ADPN positively correlated with LVMI in ≥50-year-old obese subjects with high arterial stiffness (r = 0.189, p = 0.030). The correlation coefficient between Log-ADPN and LVMI gradually changed from negative to positive with increasing risk factors for LVH. The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI. In the multivariate analysis, Log-ADPN was associated with LVMI in the subjects at risk of LVH; however, Log-ADPN was either not associated or negatively associated with LVMI in subjects at low risk of LVH.

Conclusion: Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH. Therefore, the relationship between adiponectin and LVMI varies with the risk of LVH.

Show MeSH
Related in: MedlinePlus